Dimensional Fund Advisors
VIR icon

Dimensional Fund Advisors’s Vir Biotechnology VIR Stock Holding History

Dimensional Fund Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.1M Buy
2,579,678
+43,401
+2% +$346K ﹤0.01% 1899
2025
Q4 		$15.3M Sell
2,536,277
-442,594
-15% -$2.64M ﹤0.01% 2111
2025
Q3 		$17M Sell
2,978,871
-29,084
-1% -$149K ﹤0.01% 2076
2025
Q2 		$15.2M Buy
3,007,955
+323,540
+12% +$1.73M ﹤0.01% 2088
2025
Q1 		$17.4M Buy
2,684,415
+768,950
+40% +$6.84M ﹤0.01% 2005
2024
Q4 		$14.1M Buy
1,915,465
+703,360
+58% +$5.55M ﹤0.01% 2163
2024
Q3 		$9.08M Buy
1,212,105
+574,619
+90% +$4.99M ﹤0.01% 2337
2024
Q2 		$5.67M Buy
637,486
+58,360
+10% +$560K ﹤0.01% 2455
2024
Q1 		$5.87M Buy
579,126
+110,807
+24% +$1.13M ﹤0.01% 2506
2023
Q4 		$4.71M Sell
468,319
-259,296
-36% -$2.37M ﹤0.01% 2576
2023
Q3 		$6.82M Sell
727,615
-295,124
-29% -$4.21M ﹤0.01% 2421
2023
Q2 		$25.1M Buy
1,022,739
+977,639
+2,168% +$24.6M 0.01% 1814
2023
Q1 		$1.05M Hold
45,100
– – ﹤0.01% 2893
2022
Q4 		$1.14K Hold
45,100
– – ﹤0.01% 2867
2022
Q3 		$870K Sell
45,100
-72,279
-62% -$1.84M ﹤0.01% 2920
2022
Q2 		$2.99M Sell
117,379
-494,957
-81% -$11.6M ﹤0.01% 2615
2022
Q1 		$15.7M Buy
612,336
+291,785
+91% +$8.65M ﹤0.01% 2092
2021
Q4 		$13.4M Buy
320,551
+269,069
+523% +$10.5M ﹤0.01% 2189
2021
Q3 		$2.24M Buy
51,482
+13,793
+37% +$597K ﹤0.01% 2823
2021
Q2 		$1.78M Sell
37,689
-10,381
-22% -$472K ﹤0.01% 2896
2021
Q1 		$2.46M Buy
48,070
+38,200
+387% +$2.06M ﹤0.01% 2799
2020
Q4 		$264K Buy
9,870
+274
+3% +$8.91K ﹤0.01% 3190
2020
Q3 		$329K Buy
+9,596
New +$413K ﹤0.01% 3137

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Dimensional Fund Advisors's VIR Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Vir Biotechnology (VIR) stake by 1.7% in Q1 2026, buying an estimated $346K and bringing the position to 2,579,678 shares worth $23.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Dimensional Fund Advisors first reported a position in VIR in Q3 2020 and has held it in 23 quarters since. The position peaked at $25.1M in Q2 2023. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Dimensional Fund Advisors held 2,579,678 shares of Vir Biotechnology worth $23.1M as of Q1 2026.
  • Dimensional Fund Advisors bought 43,401 Vir Biotechnology shares in Q1 2026, an estimated $346K.
  • Vir Biotechnology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1899 holding.
  • Dimensional Fund Advisors first reported a position in Vir Biotechnology in Q3 2020 and has held it in 23 quarters since.
  • Dimensional Fund Advisors's Vir Biotechnology position peaked at $25.1M in Q2 2023.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.